Primary Site >> Liver Cancer
Gene >> SOCS2
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. PMID: 18318442 |
Ref: Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis. PMID: 23475171 |
Ref: An integrated analysis of SOCS1 down-regulation in HBV infection-related hepatocellular carcinoma. PMID: 23941364 Ref: Evolution of hepatic steatosis to fibrosis and adenoma formation in liver-specific growth hormone receptor knockout mice. PMID: 25566190 |
Ref: The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma. PMID: 27465557 |
Ref: Hepatitis B Virus e Antigen Activates the Suppressor of Cytokine Signaling 2 to Repress Interferon Action. PMID: 28496097 Ref: Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma. PMID: 28717245 Ref: miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma. PMID: 28750679 |
Ref: RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. PMID: 29171881 Ref: Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling. PMID: 29196128 Ref: Potential biomarkers of HCC based on gene expression and DNA methylation profiles. PMID: 30127913 |